Patent ID: 7732139

Claim:
A microarray consisting of a set of polynucleotides and optionally, a substrate on which the set of polynucleotides is immobilized, the set of polynucleotides consisting of (a) at least one isolated polynucleotide selected from (i) a polynucleotide consisting of 15 to 100 contiguous bases of SEQ ID NO: 2 wherein the 15 to 100 contiguous bases comprises C at the 101 st position in SEQ ID NO: 2, (ii) a polynucleotide consisting of the complement of the polynucleotide of (i); (iii) a polynucleotide consisting of 15 to 100 contiguous bases of SEQ ID NO: 2 wherein the 15 to 100 contiguous bases comprises T at the 101 st position in SEQ ID NO: 2, and (iv) a polynucleotide consisting of the complement of the polynucleotide of (iii); (b) at least one isolated polynucleotide selected from (v) a polynucleotide consisting of 15 to 100 contiguous bases of SEQ ID NO: 3 wherein the 15 to 100 contiguous bases comprises G at the 101 st position in SEQ ID NO: 3, (vi) a polynucleotide consisting of the complement of the polynucleotide of (v), (vii) a polynucleotide consisting of 15 to 100 contiguous bases of SEQ ID NO: 3 wherein the 15 to 100 contiguous bases comprises T at the 101 st position in SEQ ID NO: 3, and (viii) a polynucleotide consisting of the complement of the polynucleotide of (vii); (c) at least one isolated polynucleotide selected from (ix) a polynucleotide consisting of 15 to 100 contiguous bases of SEQ ID NO: 25, wherein the 15 to 100 contiguous bases comprises C at the 101 st position in SEQ ID NO: 25, (x) a polynucleotide consisting of the complement of the polynucleotide of (ix), (xi) a polynucleotide consisting of 15 to 100 contiguous bases of SEQ ID NO: 25, wherein the 15 to 100 contiguous bases comprises T at the 101 st position in SEQ ID NO: 25, and (xii) a polynucleotide consisting of the complement of the polynucleotide of (xi); and optionally (d) at least one isolated polynucleotide consisting of 15 to 100 contiguous bases of a sequence selected from (xiii) SEQ ID NOS: 1, 4-24, and 26-35, wherein the 15 to 100 contiguous bases comprises a base at a single nucleotide polymorphism (SNP) position in the selected sequence, wherein the SNP is positioned at the 76 th nucleotide in SEQ ID NO: 4, the 85 th nucleotide in SEQ ID NO: 8, the 51 St nucleotide in SEQ ID NO: 9, the 35 th nucleotide in SEQ ID NO: 10, the 85 th nucleotide in SEQ ID NO: 19 or the 101 st nucleotide in SEQ ID NOS: 1, 5-7, 11-18, 20-24, and 26-35; or (xiv) a polynucleotide consisting of the complement of the polynucleotide of (xiii).